Silicon Nanowire Biosensor Array for Early Cancer Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cancer detection methods are inadequate for early detection, with inconsistent accuracy and high costs, often failing to detect cancer cells until significant damage has occurred, leading to late treatment and economic burdens on the healthcare system.
Innovation Solution
A silicon nanowire biosensor array with vertically aligned nanowires, allowing for easier manufacturing and increased sensitivity, measures analytes like biomarkers and proteins by altering electrical properties in response to light exposure, enabling detection of low concentrations of cancer biomarkers without the need for complex electrical contacting of individual nanowires.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional cancer detection methods (physical examination, imaging studies, routine blood tests) are used, then detection can be performed with existing technology, but detection accuracy is inconsistent and cancer cells are only detected after significant damage has occurred
Solution Approach 1:
The patent changes the detection parameter from conventional methods to nanowire electrical conductivity measurements. The nanowire biosensor detects cancer biomarkers by measuring changes in electrical conductivity when biomarkers bind to the nanowire surface, enabling detection at much lower concentrations and earlier stages than conventional methods.
Solution Approach 2:
The patent replaces mechanical/imaging-based detection systems with an electrical field-based nanowire biosensor system. The nanowires function as electrical conductors whose conductivity changes in response to biomarker binding, substituting electrical measurement for conventional physical examination and imaging approaches.
2Reliability
If targeted therapy with specialized drugs is used, then treatment efficacy is improved with less side effects, but cost of treatment increases significantly
Solution Approach 1:
The patent applies preliminary detection action using nanowire biosensors to identify cancer presence and type before treatment begins. By enabling early and accurate detection, the system allows for targeted therapy selection before treatment starts, ensuring that expensive specialized drugs are only used when truly needed and will be effective, thereby optimizing the cost-efficacy ratio.
3Measurement precision
If horizontally arranged nanowire arrays are used, then each nanowire can be individually contacted electrically, but manufacturing complexity increases and sensitivity is reduced
Solution Approach 1:
The patent transitions from horizontal to vertical nanowire arrangement, changing the spatial dimension of the nanowire array. This vertical orientation allows all nanowires to be electrically contacted at their bases through a single substrate contact plane, dramatically simplifying electrical contacting while maintaining high sensitivity through increased nanowire density.
4Quantity of substance
If early detection methods are developed, then healthcare costs can be reduced and patient outcomes improved, but detection accuracy and efficacy remain inconsistent
Solution Approach 1:
The patent changes the detection parameter to electrical conductivity measurements using nanowires, which can detect biomarkers at extremely low concentrations. This parameter change enables consistent high-accuracy detection that validates early detection approaches, potentially reducing healthcare costs by enabling earlier intervention while maintaining reliable detection accuracy.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The silicon nanowire biosensor array achieves high sensitivity and selectivity, allowing for early cancer detection at low analyte concentrations, reducing healthcare costs and improving patient outcomes by enabling earlier intervention.
Implementation Method 1
A silicon nanowire array may reduce the reflection of the silicon substrate, reduce the reflection at off-angles of incidence, and increase the absorption of the silicon in ways similar to traditional pyramids or light trapping mechanisms used in solar cells.
Implementation Method 2
measures analytes like biomarkers and proteins by altering electrical properties in response to light exposure
Data Source
AI summary
Provided is a sensor with nanowires in an aligned array. In one example, the heaviest doped region is not in the nanowire array, but in the bulk silicon substrate and the sensor is functionalized to have modified electrical properties when proteins are present.